Insider Transactions for Sarepta Therapeutics, Inc. (SRPT)

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
SRPTSarepta Therapeutics, Inc.Wigzell Hans Lennart RudolfDirectorMar 08, 2024Option Exercise$68.5830,0002,057,29537,840Mar 11, 2024, 08:02 PM
SRPTSarepta Therapeutics, Inc.Arif BilalChief Tech Ops OfficerMar 07, 2024Option Exercise$120.4950660,96825,694Mar 11, 2024, 08:00 PM
SRPTSarepta Therapeutics, Inc.Arif BilalChief Tech Ops OfficerMar 08, 2024Option Exercise$123.1447258,12225,222Mar 11, 2024, 08:00 PM
SRPTSarepta Therapeutics, Inc.Rodino-Klapac LouiseHead of R&D, CSOMar 07, 2024Option Exercise$120.4951261,69168,982Mar 11, 2024, 08:00 PM
SRPTSarepta Therapeutics, Inc.Rodino-Klapac LouiseHead of R&D, CSOMar 08, 2024Option Exercise$123.14909111,93468,073Mar 11, 2024, 08:00 PM
SRPTSarepta Therapeutics, Inc.Boor Kathryn JeanDirectorMar 11, 2024Sale$122.9376193,5507,516Mar 11, 2024, 08:00 PM
SRPTSarepta Therapeutics, Inc.Brown Ryan EdwardEVP, General CounselMar 07, 2024Option Exercise$120.4950660,96829,587Mar 11, 2024, 08:00 PM
SRPTSarepta Therapeutics, Inc.Brown Ryan EdwardEVP, General CounselMar 08, 2024Option Exercise$123.14899110,70328,688Mar 11, 2024, 08:00 PM
SRPTSarepta Therapeutics, Inc.Estepan Ian MichaelChief Financial OfficerMar 07, 2024Option Exercise$120.4952663,37837,199Mar 11, 2024, 08:00 PM
SRPTSarepta Therapeutics, Inc.Estepan Ian MichaelChief Financial OfficerMar 08, 2024Option Exercise$123.141,035127,45036,164Mar 11, 2024, 08:00 PM
SRPTSarepta Therapeutics, Inc.Estepan Ian MichaelChief Financial OfficerMar 04, 2024Option Exercise$125.321,389174,06937,725Mar 06, 2024, 08:00 PM
SRPTSarepta Therapeutics, Inc.Mayo StephenDirectorMar 05, 2024Sale$122.963,135385,4806,621Mar 06, 2024, 08:00 PM
SRPTSarepta Therapeutics, Inc.Brown Ryan EdwardEVP, General CounselMar 04, 2024Option Exercise$125.321,734217,30530,093Mar 06, 2024, 08:00 PM
SRPTSarepta Therapeutics, Inc.Arif BilalChief Tech Ops OfficerMar 04, 2024Option Exercise$125.3252265,41726,437Mar 06, 2024, 08:00 PM
SRPTSarepta Therapeutics, Inc.Rodino-Klapac LouiseHead of R&D, CSOMar 04, 2024Option Exercise$125.321,728216,55369,494Mar 06, 2024, 08:00 PM
SRPTSarepta Therapeutics, Inc.Arif BilalChief Tech Ops OfficerMar 01, 2024Option Exercise$128.432,365303,73627,293Mar 05, 2024, 08:00 PM
SRPTSarepta Therapeutics, Inc.Estepan Ian MichaelChief Financial OfficerMar 01, 2024Sale$127.811,565200,01939,114Mar 05, 2024, 08:00 PM
SRPTSarepta Therapeutics, Inc.Brown Ryan EdwardEVP, General CounselMar 01, 2024Sale$125.442,269284,62531,827Mar 05, 2024, 08:00 PM
SRPTSarepta Therapeutics, Inc.Rodino-Klapac LouiseHead of R&D, CSOMar 01, 2024Option Exercise$126.1977898,17665,222Mar 05, 2024, 08:00 PM
SRPTSarepta Therapeutics, Inc.Arif BilalChief Tech Ops OfficerDec 01, 2023Option Exercise$80.343,682295,81222,886Dec 05, 2023, 08:00 PM
SRPTSarepta Therapeutics, Inc.Rodino-Klapac LouiseHead of R&D, CSONov 17, 2023Option Exercise$82.984,508374,07465,751Nov 20, 2023, 08:00 PM
SRPTSarepta Therapeutics, Inc.Barry RichardDirectorNov 03, 2023Buy$78.8110,000788,10010,000Nov 06, 2023, 08:00 AM
SRPTSarepta Therapeutics, Inc.Barry RichardDirectorNov 03, 2023Buy$78.8140,0003,152,400140,000Nov 06, 2023, 08:00 AM
SRPTSarepta Therapeutics, Inc.INGRAM DOUGLAS SPresident & CEONov 03, 2023Buy$79.3625,2252,001,800390,307Nov 06, 2023, 08:00 AM
SRPTSarepta Therapeutics, Inc.BEHRENS M KATHLEENDirectorNov 03, 2023Option Exercise$29.0315,000435,450174,993Nov 06, 2023, 08:00 AM
SRPTSarepta Therapeutics, Inc.Chambers Michael AndrewDirectorAug 14, 2023Buy$109.479,9791,092,429246,996Aug 15, 2023, 08:00 AM
SRPTSarepta Therapeutics, Inc.Chambers Michael AndrewDirectorAug 11, 2023Buy$108.0523,6862,559,272237,017Aug 14, 2023, 08:00 AM
SRPTSarepta Therapeutics, Inc.Chambers Michael AndrewDirectorAug 10, 2023Buy$106.1534,8673,701,067213,331Aug 11, 2023, 07:40 AM
SRPTSarepta Therapeutics, Inc.Wigzell Hans Lennart RudolfDirectorAug 04, 2023Sale$67.8830,0002,036,25035,994Aug 08, 2023, 08:00 PM
SRPTSarepta Therapeutics, Inc.Brown Ryan EdwardEVP, General CounselJun 01, 2023Option Exercise$123.608911,00028,096Jun 05, 2023, 08:00 PM
SRPTSarepta Therapeutics, Inc.Arif BilalChief Tech Ops OfficerMar 30, 2023Option Exercise$136.6630741,95526,367Apr 04, 2023, 08:00 PM
SRPTSarepta Therapeutics, Inc.Rodino-Klapac LouiseHead of R&D, CSOMar 08, 2023Option Exercise$153.19912139,70970,170Mar 10, 2023, 08:00 PM
SRPTSarepta Therapeutics, Inc.Estepan Ian MichaelChief Financial OfficerMar 08, 2023Option Exercise$153.19744113,97334,679Mar 10, 2023, 08:00 PM
SRPTSarepta Therapeutics, Inc.Brown Ryan EdwardSVP, General CounselMar 08, 2023Option Exercise$153.1963597,27628,185Mar 10, 2023, 08:00 PM
SRPTSarepta Therapeutics, Inc.Arif BilalChief Tech Ops OfficerMar 08, 2023Option Exercise$153.1931448,10226,674Mar 10, 2023, 08:00 PM
SRPTSarepta Therapeutics, Inc.Arif BilalChief Tech Ops OfficerMar 06, 2023Option Exercise$157.2134053,45122,642Mar 08, 2023, 08:00 PM
SRPTSarepta Therapeutics, Inc.Estepan Ian MichaelChief Financial OfficerMar 06, 2023Option Exercise$157.211,370215,37830,923Mar 08, 2023, 08:00 PM
SRPTSarepta Therapeutics, Inc.Rodino-Klapac LouiseHead of R&D, CSOMar 06, 2023Option Exercise$157.211,134178,27666,582Mar 08, 2023, 08:00 PM
SRPTSarepta Therapeutics, Inc.Brown Ryan EdwardSVP, General CounselMar 06, 2023Option Exercise$157.211,325208,30324,491Mar 08, 2023, 08:00 PM
SRPTSarepta Therapeutics, Inc.Arif BilalChief Tech Ops OfficerMar 01, 2023Option Exercise$147.5725237,18822,837Mar 03, 2023, 08:01 PM
SRPTSarepta Therapeutics, Inc.Brown Ryan EdwardSVP, General CounselMar 01, 2023Option Exercise$147.5719628,92425,645Mar 03, 2023, 08:01 PM
SRPTSarepta Therapeutics, Inc.Estepan Ian MichaelChief Financial OfficerMar 01, 2023Option Exercise$147.5737855,78132,293Mar 03, 2023, 08:00 PM
SRPTSarepta Therapeutics, Inc.Rodino-Klapac LouiseHead of R&D, CSOMar 01, 2023Option Exercise$147.5752277,03267,716Mar 03, 2023, 08:00 PM
SRPTSarepta Therapeutics, Inc.BEHRENS M KATHLEENDirectorDec 19, 2022Option Exercise$34.9220,000698,400158,470Dec 21, 2022, 09:05 AM
SRPTSarepta Therapeutics, Inc.Rodino-Klapac LouiseHead of R&D, CSONov 17, 2022Option Exercise$108.524,211456,97867,998Nov 21, 2022, 08:02 PM
SRPTSarepta Therapeutics, Inc.Mayo StephenDirectorNov 17, 2022Sale$109.9285894,3116,387Nov 21, 2022, 08:00 PM
SRPTSarepta Therapeutics, Inc.Chambers Michael AndrewDirectorSep 14, 2022Buy$104.4357,1005,963,124108,178Sep 15, 2022, 08:00 AM
SRPTSarepta Therapeutics, Inc.Chambers Michael AndrewDirectorAug 19, 2022Buy$108.2846,1704,999,23051,078Aug 22, 2022, 08:30 AM
SRPTSarepta Therapeutics, Inc.Brown Ryan EdwardSVP, General CounselJun 01, 2022Option Exercise$72.67543,92425,841Jun 03, 2022, 08:00 PM
SRPTSarepta Therapeutics, Inc.Estepan Ian MichaelChief Financial OfficerMar 04, 2022Option Exercise$79.201,308103,59425,069Mar 08, 2022, 08:02 PM
SRPTSarepta Therapeutics, Inc.Estepan Ian MichaelChief Financial OfficerMar 07, 2022Option Exercise$79.3639831,58524,671Mar 08, 2022, 08:02 PM
SRPTSarepta Therapeutics, Inc.Brown Ryan EdwardSVP, General CounselMar 04, 2022Option Exercise$79.201,13689,97118,048Mar 08, 2022, 08:02 PM
SRPTSarepta Therapeutics, Inc.Brown Ryan EdwardSVP, General CounselMar 07, 2022Option Exercise$79.3615312,14217,895Mar 08, 2022, 08:02 PM
SRPTSarepta Therapeutics, Inc.Ciambrone WilliamEVPMar 04, 2022Option Exercise$79.201,16091,87214,099Mar 08, 2022, 08:01 PM
SRPTSarepta Therapeutics, Inc.Rodino-Klapac LouiseHead of R&D, CSOMar 04, 2022Option Exercise$79.201,21696,30764,111Mar 08, 2022, 08:00 PM
SRPTSarepta Therapeutics, Inc.Rodino-Klapac LouiseHead of R&D, CSOMar 01, 2022Option Exercise$75.0557242,92965,327Mar 01, 2022, 08:03 PM
SRPTSarepta Therapeutics, Inc.Estepan Ian MichaelChief Financial OfficerMar 01, 2022Option Exercise$75.0537628,21926,377Mar 01, 2022, 08:02 PM
SRPTSarepta Therapeutics, Inc.Brown Ryan EdwardSVP, General CounselMar 01, 2022Option Exercise$75.0518413,80919,184Mar 01, 2022, 08:01 PM
SRPTSarepta Therapeutics, Inc.BEHRENS M KATHLEENDirectorDec 15, 2021Option Exercise$10.085,00050,400135,517Dec 16, 2021, 08:00 PM
SRPTSarepta Therapeutics, Inc.Rodino-Klapac LouiseHead of R&D, CSONov 24, 2021Buy$79.333,780299,86765,678Nov 29, 2021, 08:00 AM
SRPTSarepta Therapeutics, Inc.INGRAM DOUGLAS SPresident & CEONov 17, 2021Buy$79.9425,0262,000,579365,082Nov 17, 2021, 06:24 PM
SRPTSarepta Therapeutics, Inc.Estepan Ian MichaelChief Financial OfficerSep 08, 2021Option Exercise$78.291,623127,06526,753Sep 09, 2021, 08:00 PM
SRPTSarepta Therapeutics, Inc.INGRAM DOUGLAS SPresident & CEOJun 26, 2021Option Exercise$80.4017,8121,432,085340,056Jun 28, 2021, 08:00 PM
SRPTSarepta Therapeutics, Inc.BEHRENS M KATHLEENDirectorMar 10, 2021Option Exercise$64.0310,000640,300135,517Mar 10, 2021, 08:04 PM
SRPTSarepta Therapeutics, Inc.Wigzell Hans Lennart RudolfDirectorMar 08, 2021Option Exercise$59.2220,0001,184,30026,518Mar 10, 2021, 08:03 PM
SRPTSarepta Therapeutics, Inc.O'Neill Gilmore NeilEVP, R&D & CMOFeb 28, 2021Option Exercise$86.9752445,57213,546Mar 10, 2021, 08:02 PM
SRPTSarepta Therapeutics, Inc.Brown Ryan EdwardSVP, General CounselFeb 28, 2021Option Exercise$86.9721618,7864,622Mar 10, 2021, 08:01 PM
SRPTSarepta Therapeutics, Inc.Brown Ryan EdwardSVP, General CounselMar 04, 2021Option Exercise$80.7619015,34419,432Mar 10, 2021, 08:01 PM
SRPTSarepta Therapeutics, Inc.Rodino-Klapac LouiseChief Scientific OfficerFeb 28, 2021Option Exercise$86.9756549,1386,604Mar 10, 2021, 08:01 PM
SRPTSarepta Therapeutics, Inc.Estepan Ian MichaelChief Financial OfficerFeb 28, 2021Option Exercise$86.9731927,74313,723Mar 10, 2021, 08:00 PM
SRPTSarepta Therapeutics, Inc.Estepan Ian MichaelChief Financial OfficerMar 05, 2021Option Exercise$84.6534729,37428,376Mar 10, 2021, 08:00 PM
SRPTSarepta Therapeutics, Inc.INGRAM DOUGLAS SPresident & CEODec 31, 2020Option Exercise$170.4937,1446,332,681357,868Jan 04, 2021, 08:00 PM
SRPTSarepta Therapeutics, Inc.Bratica JosephPrincipal Financial OfficerDec 11, 2020Sale$118.222,230263,6429,255Dec 14, 2020, 08:00 PM
SRPTSarepta Therapeutics, Inc.Bratica JosephPrincipal Financial OfficerDec 08, 2020Sale$94.802,250213,3009,265Dec 10, 2020, 08:23 PM
SRPTSarepta Therapeutics, Inc.Wigzell Hans Lennart RudolfDirectorAug 10, 2020Sale$96.9620,0001,939,24423,792Aug 11, 2020, 08:00 PM
SRPTSarepta Therapeutics, Inc.Barry RichardDirectorAug 07, 2020Sale$158.5030,0004,754,9723,132,280Aug 07, 2020, 08:00 PM
SRPTSarepta Therapeutics, Inc.Bratica JosephPrincipal Financial OfficerAug 03, 2020Sale$92.302,250207,6758,957Aug 05, 2020, 08:00 PM
SRPTSarepta Therapeutics, Inc.Mahatme SandeshEVP, CFO & CBOJul 08, 2020Option Exercise$19.693,80674,94120,260Jul 09, 2020, 08:00 PM
SRPTSarepta Therapeutics, Inc.Howton David TEVP, General CounselJun 22, 2020Sale$98.32210,24420,671,272136,993Jun 22, 2020, 09:17 PM
SRPTSarepta Therapeutics, Inc.Wigzell Hans Lennart RudolfDirectorMay 20, 2020Sale$80.3610,000803,61018,792May 22, 2020, 08:00 PM
SRPTSarepta Therapeutics, Inc.Barry RichardDirectorMay 15, 2020Sale$141.2630,0004,237,9463,163,813May 15, 2020, 09:02 PM
SRPTSarepta Therapeutics, Inc.Wigzell Hans Lennart RudolfDirectorMar 04, 2020Sale$62.6710,000626,75018,792Mar 06, 2020, 08:01 PM
SRPTSarepta Therapeutics, Inc.INGRAM DOUGLAS SPresident & CEODec 31, 2019Option Exercise$129.0437,1854,798,352395,012Jan 03, 2020, 08:00 PM
SRPTSarepta Therapeutics, Inc.Cumbo AlexanderEVP, Chief Commercial OfficerDec 13, 2019Sale$80.9374,7066,046,23243,867Dec 17, 2019, 08:02 PM
SRPTSarepta Therapeutics, Inc.Howton David TEVP, General CounselDec 13, 2019Sale$73.49156,00011,464,439103,171Dec 17, 2019, 08:01 PM
SRPTSarepta Therapeutics, Inc.Mahatme SandeshEVP, CFO & CBODec 13, 2019Option Exercise$77.19250,00019,297,943155,179Dec 17, 2019, 08:00 PM
SRPTSarepta Therapeutics, Inc.Howton David TEVP, General CounselNov 22, 2019Sale$56.0262,0763,477,75136,993Nov 26, 2019, 08:01 PM
SRPTSarepta Therapeutics, Inc.Barry RichardDirectorSep 12, 2019Buy$87.491,691147,9503,183,756Sep 16, 2019, 08:00 AM
SRPTSarepta Therapeutics, Inc.Barry RichardDirectorSep 13, 2019Buy$87.493,309289,5043,187,065Sep 16, 2019, 08:00 AM
SRPTSarepta Therapeutics, Inc.BONNEY MICHAEL WDirectorSep 09, 2019Buy$86.742,000173,4807,051Sep 09, 2019, 02:18 PM
SRPTSarepta Therapeutics, Inc.BEHRENS M KATHLEENDirectorSep 05, 2019Option Exercise$7.805,00039,000123,167Sep 06, 2019, 02:13 PM
SRPTSarepta Therapeutics, Inc.BEHRENS M KATHLEENDirectorSep 06, 2019Buy$87.982,500219,950125,667Sep 06, 2019, 02:13 PM
SRPTSarepta Therapeutics, Inc.Mahatme SandeshEVP, CFO & CBOAug 21, 2019Option Exercise$52.19157,4658,217,698130,179Aug 22, 2019, 07:20 PM
SRPTSarepta Therapeutics, Inc.Barry RichardDirectorAug 20, 2019Buy$99.325,000496,5923,182,065Aug 20, 2019, 05:43 PM
SRPTSarepta Therapeutics, Inc.Mahatme SandeshEVP, CFO & CBOAug 15, 2019Option Exercise$24.739,754241,23230,179Aug 15, 2019, 04:33 PM
SRPTSarepta Therapeutics, Inc.Barry RichardDirectorAug 14, 2019Buy$122.503,700453,2503,177,065Aug 14, 2019, 04:38 PM
SRPTSarepta Therapeutics, Inc.Barry RichardDirectorAug 12, 2019Buy$122.501,300159,2503,173,365Aug 13, 2019, 04:31 PM
SRPTSarepta Therapeutics, Inc.INGRAM DOUGLAS SPresident & CEOAug 12, 2019Buy$123.0716,2522,000,160432,197Aug 12, 2019, 05:48 PM
SRPTSarepta Therapeutics, Inc.O'Neill Gilmore NeilEVP, R&D & CMOMay 24, 2019Option Exercise$119.314,630552,4057,370May 24, 2019, 08:07 PM
SRPTSarepta Therapeutics, Inc.Wigzell Hans Lennart RudolfDirectorMay 23, 2019Option Exercise$63.9020,0001,278,00021,717May 24, 2019, 08:03 PM